APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,131 | -41.0% | 23,396 | -57.3% | 0.02% | -41.7% |
Q1 2023 | $3,610 | -11.1% | 54,732 | -30.3% | 0.04% | -16.3% |
Q4 2022 | $4,059 | -99.9% | 78,486 | -24.4% | 0.04% | -48.2% |
Q3 2022 | $7,090,000 | -3.4% | 103,802 | -28.1% | 0.08% | +15.3% |
Q1 2022 | $7,340,000 | +11.8% | 144,468 | +4.0% | 0.07% | +24.1% |
Q4 2021 | $6,568,000 | +51.9% | 138,931 | +5.9% | 0.06% | +45.0% |
Q3 2021 | $4,324,000 | -41.3% | 131,190 | +12.5% | 0.04% | -41.2% |
Q2 2021 | $7,371,000 | +51.9% | 116,628 | +3.2% | 0.07% | +41.7% |
Q1 2021 | $4,851,000 | -19.3% | 113,036 | +7.5% | 0.05% | -20.0% |
Q4 2020 | $6,013,000 | +105.4% | 105,144 | +8.3% | 0.06% | +81.8% |
Q3 2020 | $2,928,000 | -2.2% | 97,083 | +5.9% | 0.03% | -8.3% |
Q2 2020 | $2,994,000 | +47.8% | 91,678 | +21.2% | 0.04% | +28.6% |
Q1 2020 | $2,026,000 | +69.7% | 75,614 | +93.9% | 0.03% | +115.4% |
Q4 2019 | $1,194,000 | +16.3% | 38,998 | -8.5% | 0.01% | +8.3% |
Q3 2019 | $1,027,000 | -5.0% | 42,644 | 0.0% | 0.01% | -7.7% |
Q2 2019 | $1,081,000 | +35.0% | 42,644 | +3.8% | 0.01% | +30.0% |
Q1 2019 | $801,000 | – | 41,071 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 1,526,122 | $29,759,000 | 24.10% |
Cormorant Asset Management, LP | 3,600,000 | $70,200,000 | 4.74% |
SECTORAL ASSET MANAGEMENT INC | 1,727,829 | $33,693,000 | 4.05% |
Hillhouse Capital Management | 2,098,581 | $40,922,000 | 1.71% |
HHLR ADVISORS, LTD. | 2,579,708 | $50,304,000 | 1.40% |
CLOUGH CAPITAL PARTNERS L P | 589,734 | $11,500,000 | 1.01% |
Vivo Capital, LLC | 383,538 | $7,479,000 | 0.75% |
Opaleye Management Inc. | 115,000 | $2,243,000 | 0.62% |
Virtus ETF Advisers LLC | 14,338 | $280,000 | 0.60% |
Eversept Partners, LP | 104,349 | $2,034,806 | 0.59% |